Trials / Unknown
UnknownNCT04817150
3D vs 2D-laparoscopy for Rectocele and Rectal Prolapse Correction: a Prospective, Randomized, Single Center Study
LARC Study: Three-dimensional Versus Conventional 2D-laparoscopy for Rectocele and Rectal Prolapse Repair: a Prospective, Randomized, Single Center Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Alexander Khitaryan · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim is to compare proximate and remote results of 3D and conventional 2D laparoscopic interventions in terms of efficacy and safety in treatment of symptomatic rectocele and rectal prolapse. This is a prospective randomized comparative study in parallel groups conducted in single Colorectal unit. Inclusion criteria: female patients with stage 3 rectocele (3-4 POP-Q \[pelvic organ prolapse quantification\] grade) and/or full-thickness rectal prolapse. Intervention - laparoscopic ventral rectopexy. The primary outcome is objective cure rate of pelvic prolapse. Secondary outcomes include obstructive defecation and incontinence symptoms according to Wexner and Cleveland Clinic scales, and satisfaction according to Patient Global Impression of Improvement questionnaire. Operative times, intraoperative blood loss, length of hospital stay, postop pain severity, urinary incontinence, as well as surgical and mesh complications are also assessed. The specific point of interest in this study is surgeon's tiredness after the operation assessed with Profile of Mood States questionnaire.
Conditions
- Rectocele; Female
- Rectocele and Incomplete Uterine Prolapse
- Rectocele and Complete Uterovaginal Prolapse
- Rectal Prolapse
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic ventral mesh rectopexy | Conventional laparoscopic ventral mesh rectopexy, as first described by D'Hoore |
Timeline
- Start date
- 2021-03-10
- Primary completion
- 2022-06-01
- Completion
- 2022-07-01
- First posted
- 2021-03-26
- Last updated
- 2021-04-19
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04817150. Inclusion in this directory is not an endorsement.